Literature DB >> 35037970

[S2K guideline on the diagnosis and treatment of interstitial cystitis (IC/BPS) : Discussion of the current guideline using a case study].

J Tolle1, B T Kaftan2, Th Bschleipfer3.   

Abstract

IC/BPS is a chronic progressive disorder that is often difficult and unsatisfactory for the person affected and the treating therapist. Treatment should therefore be comprehensive, interdisciplinary, multimodal and take into account the biopsychosocial model. The guideline forms a thread through the diverse diagnostic and therapeutic options and provides extensive background information on the definition, epidemiology and aetiopathogenesis of this rare disease. However, practice and theory/guideline are different. Adaptation to the individual case is therefore necessary and explicitly desired. The guideline should therefore serve as a source of ideas for colleagues to compile their own standards suitable for their practice. On the one hand, therapy approaches that have been tried and tested in everyday clinical practice are passed on. On the other hand, the frequent lack of evidence should also be viewed critically. Further studies, if possible multi-centre, specifically designed for different aspects of IC/BPS would be desirable. Close networking between therapists in private practice and special centres is essential for the best possible treatment of people with IC/BPS. The guideline is intended to show the limits of what can be done in practices and outpatient clinics and to provide guidance on when patients should be referred to a "Centre for Interstitial Cystitis and Pelvic Pain". Overall, the guideline has improved the presence of this rare disease among colleagues. A comprehensive supplement, update and further substantiation with the state of current research is thus desirable.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Botulinum toxins; Differential diagnosis; Glomerulation; Hydrodistention; Urinary bladder

Mesh:

Year:  2022        PMID: 35037970     DOI: 10.1007/s00120-021-01753-9

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  13 in total

1.  Conservative therapy of interstitial cystitis.

Authors:  P M Hanno; A J Wein
Journal:  Semin Urol       Date:  1991-05

2.  The public understanding of science.

Authors:  J R Durant; G A Evans; G P Thomas
Journal:  Nature       Date:  1989-07-06       Impact factor: 49.962

3.  Death.

Authors: 
Journal:  J Radiol Electrol Med Nucl       Date:  1970 Jan-Feb

4.  [Sero-epidemiological studies of the adult population at the time of an epidemic caused by A2 influenza virus (Hong Kong variant) which occurred in Rome in the winter of 1969-1970].

Authors:  G Rocchi; A Muzzi; V Giannini
Journal:  Nuovi Ann Ig Microbiol       Date:  1970 Mar-Apr

5.  Electrosurgical management of Hunner ulcers in a referral center's interstitial cystitis population.

Authors:  Avinash Chennamsetty; Iyad Khourdaji; Jonathan Goike; Kim A Killinger; Benjamin Girdler; Kenneth M Peters
Journal:  Urology       Date:  2014-11-05       Impact factor: 2.649

6.  Endoscopic ablation of Hunner's lesions in interstitial cystitis patients.

Authors:  Ryan A Payne; R Corey O'Connor; Margarita Kressin; Michael L Guralnick
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

7.  The use of amitriptyline in patients with urinary frequency and pain.

Authors:  K Pranikoff; G Constantino
Journal:  Urology       Date:  1998-05       Impact factor: 2.649

Review 8.  Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal.

Authors:  Joop P van de Merwe; Jørgen Nordling; Pierre Bouchelouche; Kirsten Bouchelouche; Mauro Cervigni; L Kurosch Daha; Suzy Elneil; Magnus Fall; Gero Hohlbrugger; Paul Irwin; Svend Mortensen; Arndt van Ophoven; John L Osborne; Ralph Peeker; Benedikte Richter; Claus Riedl; Jukka Sairanen; Martina Tinzl; Jean-Jacques Wyndaele
Journal:  Eur Urol       Date:  2007-09-20       Impact factor: 20.096

9.  Fulguration for Hunner ulcers: long-term clinical outcomes.

Authors:  Joel H Hillelsohn; Soroush Rais-Bahrami; Justin I Friedlander; Zhamshid Okhunov; Mahyar Kashan; Lisa Rosen; Robert M Moldwin
Journal:  J Urol       Date:  2012-10-22       Impact factor: 7.450

10.  Hunner-Type (Classic) Interstitial Cystitis: A Distinct Inflammatory Disorder Characterized by Pancystitis, with Frequent Expansion of Clonal B-Cells and Epithelial Denudation.

Authors:  Daichi Maeda; Yoshiyuki Akiyama; Teppei Morikawa; Akiko Kunita; Yasunori Ota; Hiroto Katoh; Aya Niimi; Akira Nomiya; Shumpei Ishikawa; Akiteru Goto; Yasuhiko Igawa; Masashi Fukayama; Yukio Homma
Journal:  PLoS One       Date:  2015-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.